nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—PSMA1—mouth—Behcet's disease	0.0298	0.0456	CbGeAlD
Bortezomib—CTSG—skin of body—Behcet's disease	0.0172	0.0263	CbGeAlD
Bortezomib—PSMA1—skin of body—Behcet's disease	0.0165	0.0252	CbGeAlD
Bortezomib—PSMD1—eye—Behcet's disease	0.0159	0.0243	CbGeAlD
Bortezomib—PSMD1—retina—Behcet's disease	0.0158	0.0241	CbGeAlD
Bortezomib—CTSG—mammalian vulva—Behcet's disease	0.0157	0.0239	CbGeAlD
Bortezomib—CTSG—cardiac atrium—Behcet's disease	0.015	0.0229	CbGeAlD
Bortezomib—PSMD2—eye—Behcet's disease	0.0141	0.0216	CbGeAlD
Bortezomib—PSMD2—retina—Behcet's disease	0.014	0.0214	CbGeAlD
Bortezomib—PSMD1—mammalian vulva—Behcet's disease	0.0126	0.0193	CbGeAlD
Bortezomib—PSMD2—skin of body—Behcet's disease	0.0123	0.0187	CbGeAlD
Bortezomib—PSMD1—cardiac atrium—Behcet's disease	0.0121	0.0185	CbGeAlD
Bortezomib—PSMD1—medulla oblongata—Behcet's disease	0.0114	0.0174	CbGeAlD
Bortezomib—PSMD2—mammalian vulva—Behcet's disease	0.0112	0.0171	CbGeAlD
Bortezomib—PSMB8—mammalian vulva—Behcet's disease	0.0111	0.017	CbGeAlD
Bortezomib—PSMB1—eye—Behcet's disease	0.0108	0.0165	CbGeAlD
Bortezomib—PSMD2—cardiac atrium—Behcet's disease	0.0107	0.0164	CbGeAlD
Bortezomib—PSMB2—eye—Behcet's disease	0.0106	0.0161	CbGeAlD
Bortezomib—PSMB2—retina—Behcet's disease	0.0105	0.016	CbGeAlD
Bortezomib—PSMD1—midbrain—Behcet's disease	0.0104	0.0159	CbGeAlD
Bortezomib—PSMA1—nervous system—Behcet's disease	0.0102	0.0156	CbGeAlD
Bortezomib—PSMD1—spinal cord—Behcet's disease	0.0102	0.0155	CbGeAlD
Bortezomib—PSMD2—medulla oblongata—Behcet's disease	0.0101	0.0154	CbGeAlD
Bortezomib—PSMA1—central nervous system—Behcet's disease	0.00982	0.015	CbGeAlD
Bortezomib—PSMB5—mammalian vulva—Behcet's disease	0.00982	0.015	CbGeAlD
Bortezomib—PSMB1—skin of body—Behcet's disease	0.00941	0.0144	CbGeAlD
Bortezomib—PSMB5—cardiac atrium—Behcet's disease	0.00941	0.0144	CbGeAlD
Bortezomib—PSMD2—midbrain—Behcet's disease	0.00923	0.0141	CbGeAlD
Bortezomib—PSMB2—skin of body—Behcet's disease	0.00918	0.014	CbGeAlD
Bortezomib—PSMD2—spinal cord—Behcet's disease	0.00901	0.0138	CbGeAlD
Bortezomib—PSMB5—medulla oblongata—Behcet's disease	0.00887	0.0136	CbGeAlD
Bortezomib—PSMB1—mammalian vulva—Behcet's disease	0.00859	0.0131	CbGeAlD
Bortezomib—PSMB2—mammalian vulva—Behcet's disease	0.00838	0.0128	CbGeAlD
Bortezomib—PSMB1—cardiac atrium—Behcet's disease	0.00822	0.0126	CbGeAlD
Bortezomib—PSMB5—midbrain—Behcet's disease	0.0081	0.0124	CbGeAlD
Bortezomib—PSMB2—cardiac atrium—Behcet's disease	0.00802	0.0123	CbGeAlD
Bortezomib—PSMB5—spinal cord—Behcet's disease	0.00791	0.0121	CbGeAlD
Bortezomib—PSMA1—brain—Behcet's disease	0.0078	0.0119	CbGeAlD
Bortezomib—PSMB1—medulla oblongata—Behcet's disease	0.00775	0.0118	CbGeAlD
Bortezomib—PSMD2—nervous system—Behcet's disease	0.00759	0.0116	CbGeAlD
Bortezomib—PSMB2—medulla oblongata—Behcet's disease	0.00756	0.0116	CbGeAlD
Bortezomib—PSMD2—central nervous system—Behcet's disease	0.00731	0.0112	CbGeAlD
Bortezomib—SLC31A1—mammalian vulva—Behcet's disease	0.00725	0.0111	CbGeAlD
Bortezomib—PSMB1—midbrain—Behcet's disease	0.00708	0.0108	CbGeAlD
Bortezomib—SLC31A1—cardiac atrium—Behcet's disease	0.00695	0.0106	CbGeAlD
Bortezomib—PSMB2—midbrain—Behcet's disease	0.00691	0.0106	CbGeAlD
Bortezomib—PSMB1—spinal cord—Behcet's disease	0.00691	0.0106	CbGeAlD
Bortezomib—PSMB2—spinal cord—Behcet's disease	0.00674	0.0103	CbGeAlD
Bortezomib—PTGS1—artery—Behcet's disease	0.00658	0.0101	CbGeAlD
Bortezomib—SLC31A1—medulla oblongata—Behcet's disease	0.00655	0.01	CbGeAlD
Bortezomib—PSMD1—brain—Behcet's disease	0.00655	0.01	CbGeAlD
Bortezomib—SLC31A1—midbrain—Behcet's disease	0.00599	0.00915	CbGeAlD
Bortezomib—SLC31A1—spinal cord—Behcet's disease	0.00584	0.00893	CbGeAlD
Bortezomib—PSMB1—nervous system—Behcet's disease	0.00582	0.0089	CbGeAlD
Bortezomib—PSMD2—brain—Behcet's disease	0.0058	0.00887	CbGeAlD
Bortezomib—PSMB8—brain—Behcet's disease	0.00577	0.00881	CbGeAlD
Bortezomib—PSMB2—nervous system—Behcet's disease	0.00568	0.00868	CbGeAlD
Bortezomib—PSMB1—central nervous system—Behcet's disease	0.00561	0.00857	CbGeAlD
Bortezomib—PTGS1—endothelium—Behcet's disease	0.00556	0.0085	CbGeAlD
Bortezomib—PSMB2—central nervous system—Behcet's disease	0.00547	0.00836	CbGeAlD
Bortezomib—PTGS1—blood vessel—Behcet's disease	0.00513	0.00783	CbGeAlD
Bortezomib—PSMB5—brain—Behcet's disease	0.00509	0.00778	CbGeAlD
Bortezomib—SLC31A1—nervous system—Behcet's disease	0.00492	0.00752	CbGeAlD
Bortezomib—CYP1A1—mouth—Behcet's disease	0.00488	0.00746	CbGeAlD
Bortezomib—SLC31A1—central nervous system—Behcet's disease	0.00474	0.00724	CbGeAlD
Bortezomib—PSMB1—brain—Behcet's disease	0.00445	0.0068	CbGeAlD
Bortezomib—PSMB2—brain—Behcet's disease	0.00434	0.00664	CbGeAlD
Bortezomib—SLC31A1—brain—Behcet's disease	0.00376	0.00575	CbGeAlD
Bortezomib—CYP1A1—skin of body—Behcet's disease	0.0027	0.00413	CbGeAlD
Bortezomib—CYP1A1—mammalian vulva—Behcet's disease	0.00246	0.00377	CbGeAlD
Bortezomib—PTGS1—skin of body—Behcet's disease	0.00237	0.00363	CbGeAlD
Bortezomib—CYP1A1—cardiac atrium—Behcet's disease	0.00236	0.00361	CbGeAlD
Bortezomib—CYP2D6—brainstem—Behcet's disease	0.0023	0.00352	CbGeAlD
Bortezomib—PTGS1—mammalian vulva—Behcet's disease	0.00216	0.00331	CbGeAlD
Bortezomib—PTGS1—cardiac atrium—Behcet's disease	0.00207	0.00317	CbGeAlD
Bortezomib—PTGS1—spinal cord—Behcet's disease	0.00174	0.00266	CbGeAlD
Bortezomib—CYP1A1—nervous system—Behcet's disease	0.00167	0.00255	CbGeAlD
Bortezomib—CYP1A1—central nervous system—Behcet's disease	0.00161	0.00246	CbGeAlD
Bortezomib—PTGS1—nervous system—Behcet's disease	0.00147	0.00224	CbGeAlD
Bortezomib—PTGS1—central nervous system—Behcet's disease	0.00141	0.00216	CbGeAlD
Bortezomib—CYP2C8—brain—Behcet's disease	0.00138	0.00212	CbGeAlD
Bortezomib—CYP1A1—brain—Behcet's disease	0.00128	0.00195	CbGeAlD
Bortezomib—PSMB8—Interferon Signaling—ICAM1—Behcet's disease	0.00123	0.00356	CbGpPWpGaD
Bortezomib—CYP3A4—nervous system—Behcet's disease	0.00123	0.00187	CbGeAlD
Bortezomib—CYP2D6—nervous system—Behcet's disease	0.00121	0.00184	CbGeAlD
Bortezomib—PSMB5—Adaptive Immune System—ITGB2—Behcet's disease	0.0012	0.00348	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—ITGB2—Behcet's disease	0.0012	0.00348	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—ITGB2—Behcet's disease	0.0012	0.00348	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—ITGB2—Behcet's disease	0.00118	0.00343	CbGpPWpGaD
Bortezomib—CYP3A4—central nervous system—Behcet's disease	0.00118	0.0018	CbGeAlD
Bortezomib—CYP2D6—central nervous system—Behcet's disease	0.00116	0.00178	CbGeAlD
Bortezomib—PTGS1—Selenium Micronutrient Network—APOA1—Behcet's disease	0.00116	0.00334	CbGpPWpGaD
Bortezomib—CYP1A2—Tryptophan metabolism—CAT—Behcet's disease	0.00114	0.00329	CbGpPWpGaD
Bortezomib—PTGS1—brain—Behcet's disease	0.00112	0.00172	CbGeAlD
Bortezomib—PSMB5—Class I MHC mediated antigen processing & presentation—HLA-B—Behcet's disease	0.00111	0.00322	CbGpPWpGaD
Bortezomib—PSMB1—Class I MHC mediated antigen processing & presentation—HLA-B—Behcet's disease	0.00111	0.00322	CbGpPWpGaD
Bortezomib—PSMB2—Class I MHC mediated antigen processing & presentation—HLA-B—Behcet's disease	0.00111	0.00322	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—MEFV—Behcet's disease	0.00111	0.0032	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—MEFV—Behcet's disease	0.00111	0.0032	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—MEFV—Behcet's disease	0.00111	0.0032	CbGpPWpGaD
Bortezomib—SLC31A1—Transmembrane transport of small molecules—APOA1—Behcet's disease	0.0011	0.00319	CbGpPWpGaD
Bortezomib—PSMB8—Class I MHC mediated antigen processing & presentation—HLA-B—Behcet's disease	0.0011	0.00318	CbGpPWpGaD
Bortezomib—PTGS1—Selenium Micronutrient Network—ICAM1—Behcet's disease	0.0011	0.00318	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—MEFV—Behcet's disease	0.00109	0.00315	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—ITGAL—Behcet's disease	0.00108	0.00314	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—ITGAL—Behcet's disease	0.00108	0.00314	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—ITGAL—Behcet's disease	0.00108	0.00314	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—ITGAL—Behcet's disease	0.00107	0.00309	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—HLA-B—Behcet's disease	0.00101	0.00292	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—ERAP1—Behcet's disease	0.000985	0.00285	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—ERAP1—Behcet's disease	0.000985	0.00285	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—ERAP1—Behcet's disease	0.000985	0.00285	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—CTLA4—Behcet's disease	0.000984	0.00285	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—CTLA4—Behcet's disease	0.00098	0.00283	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—CTLA4—Behcet's disease	0.000975	0.00282	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—ERAP1—Behcet's disease	0.000972	0.00281	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—ITGB2—Behcet's disease	0.000962	0.00278	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—ITGB2—Behcet's disease	0.000957	0.00277	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—ITGB2—Behcet's disease	0.000953	0.00276	CbGpPWpGaD
Bortezomib—CTSG—Metabolism of proteins—CXCL8—Behcet's disease	0.000926	0.00268	CbGpPWpGaD
Bortezomib—CYP2D6—brain—Behcet's disease	0.000922	0.00141	CbGeAlD
Bortezomib—PTGS1—Selenium Micronutrient Network—SERPINE1—Behcet's disease	0.000918	0.00266	CbGpPWpGaD
Bortezomib—CYP3A4—Tryptophan metabolism—CAT—Behcet's disease	0.000877	0.00254	CbGpPWpGaD
Bortezomib—PSMA1—Apoptosis—TNF—Behcet's disease	0.000868	0.00251	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—ITGAL—Behcet's disease	0.000868	0.00251	CbGpPWpGaD
Bortezomib—PSMD1—Apoptosis—TNF—Behcet's disease	0.000864	0.0025	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—ITGAL—Behcet's disease	0.000863	0.0025	CbGpPWpGaD
Bortezomib—PSMD2—Apoptosis—TNF—Behcet's disease	0.00086	0.00249	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—ITGAL—Behcet's disease	0.000859	0.00249	CbGpPWpGaD
Bortezomib—PSMB8—Cytokine Signaling in Immune system—ICAM1—Behcet's disease	0.000821	0.00237	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—CTLA4—Behcet's disease	0.000746	0.00216	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—CTLA4—Behcet's disease	0.000746	0.00216	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—CTLA4—Behcet's disease	0.000746	0.00216	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—CTLA4—Behcet's disease	0.000736	0.00213	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—ITGB2—Behcet's disease	0.000729	0.00211	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—ITGB2—Behcet's disease	0.000729	0.00211	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—ITGB2—Behcet's disease	0.000729	0.00211	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—HLA-B—Behcet's disease	0.000728	0.00211	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—HLA-B—Behcet's disease	0.000725	0.0021	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—HLA-B—Behcet's disease	0.000721	0.00209	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—ITGB2—Behcet's disease	0.000719	0.00208	CbGpPWpGaD
Bortezomib—CYP1A1—PPARA activates gene expression—APOA1—Behcet's disease	0.000682	0.00197	CbGpPWpGaD
Bortezomib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—APOA1—Behcet's disease	0.000667	0.00193	CbGpPWpGaD
Bortezomib—PSMB5—Apoptosis—TNF—Behcet's disease	0.000658	0.0019	CbGpPWpGaD
Bortezomib—PSMB1—Apoptosis—TNF—Behcet's disease	0.000658	0.0019	CbGpPWpGaD
Bortezomib—PSMB2—Apoptosis—TNF—Behcet's disease	0.000658	0.0019	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—ITGAL—Behcet's disease	0.000658	0.0019	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—ITGAL—Behcet's disease	0.000658	0.0019	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—ITGAL—Behcet's disease	0.000658	0.0019	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CCR1—Behcet's disease	0.000654	0.00189	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CCR1—Behcet's disease	0.000651	0.00188	CbGpPWpGaD
Bortezomib—PSMB8—Apoptosis—TNF—Behcet's disease	0.000649	0.00188	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—ITGAL—Behcet's disease	0.000648	0.00188	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—CCR1—Behcet's disease	0.000648	0.00187	CbGpPWpGaD
Bortezomib—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.000641	0.00185	CbGpPWpGaD
Bortezomib—CYP1A1—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.000641	0.00185	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CTLA4—Behcet's disease	0.000597	0.00173	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CTLA4—Behcet's disease	0.000594	0.00172	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—ICAM1—Behcet's disease	0.000592	0.00171	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CTLA4—Behcet's disease	0.000591	0.00171	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—ICAM1—Behcet's disease	0.000589	0.0017	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—ICAM1—Behcet's disease	0.000586	0.00169	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—HLA-B—Behcet's disease	0.000552	0.0016	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—HLA-B—Behcet's disease	0.000552	0.0016	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—HLA-B—Behcet's disease	0.000552	0.0016	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—HLA-B—Behcet's disease	0.000544	0.00157	CbGpPWpGaD
Bortezomib—PTGS1—Selenium Micronutrient Network—TNF—Behcet's disease	0.000541	0.00157	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CCR1—Behcet's disease	0.000496	0.00143	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CCR1—Behcet's disease	0.000496	0.00143	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CCR1—Behcet's disease	0.000496	0.00143	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CCR1—Behcet's disease	0.000489	0.00141	CbGpPWpGaD
Bortezomib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—APOA1—Behcet's disease	0.00046	0.00133	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CTLA4—Behcet's disease	0.000452	0.00131	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CTLA4—Behcet's disease	0.000452	0.00131	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CTLA4—Behcet's disease	0.000452	0.00131	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—ICAM1—Behcet's disease	0.000448	0.0013	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—ICAM1—Behcet's disease	0.000448	0.0013	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—ICAM1—Behcet's disease	0.000448	0.0013	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CTLA4—Behcet's disease	0.000446	0.00129	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—ICAM1—Behcet's disease	0.000442	0.00128	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—HLA-B—Behcet's disease	0.000442	0.00128	CbGpPWpGaD
Bortezomib—PSMA1—Disease—APOB—Behcet's disease	0.000441	0.00127	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—HLA-B—Behcet's disease	0.00044	0.00127	CbGpPWpGaD
Bortezomib—PSMD1—Disease—APOB—Behcet's disease	0.000439	0.00127	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—HLA-B—Behcet's disease	0.000437	0.00127	CbGpPWpGaD
Bortezomib—PSMD2—Disease—APOB—Behcet's disease	0.000437	0.00126	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Behcet's disease	0.000408	0.00118	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Behcet's disease	0.000408	0.00118	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—CAT—Behcet's disease	0.00038	0.0011	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—CAT—Behcet's disease	0.000378	0.00109	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—CAT—Behcet's disease	0.000377	0.00109	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—APOB—Behcet's disease	0.000369	0.00107	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—APOB—Behcet's disease	0.000367	0.00106	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—APOB—Behcet's disease	0.000366	0.00106	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—ICAM1—Behcet's disease	0.000359	0.00104	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—ICAM1—Behcet's disease	0.000357	0.00103	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—ICAM1—Behcet's disease	0.000355	0.00103	CbGpPWpGaD
Bortezomib—PSMA1—Disease—APOA1—Behcet's disease	0.000349	0.00101	CbGpPWpGaD
Bortezomib—PSMD1—Disease—APOA1—Behcet's disease	0.000347	0.001	CbGpPWpGaD
Bortezomib—PSMD2—Disease—APOA1—Behcet's disease	0.000345	0.000999	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—HLA-B—Behcet's disease	0.000335	0.000968	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—HLA-B—Behcet's disease	0.000335	0.000968	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—HLA-B—Behcet's disease	0.000335	0.000968	CbGpPWpGaD
Bortezomib—PSMB5—Disease—APOB—Behcet's disease	0.000334	0.000966	CbGpPWpGaD
Bortezomib—PSMB1—Disease—APOB—Behcet's disease	0.000334	0.000966	CbGpPWpGaD
Bortezomib—PSMB2—Disease—APOB—Behcet's disease	0.000334	0.000966	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—HLA-B—Behcet's disease	0.00033	0.000954	CbGpPWpGaD
Bortezomib—PSMB8—Disease—APOB—Behcet's disease	0.000329	0.000952	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000328	0.00095	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—APOB—Behcet's disease	0.000309	0.000893	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—APOB—Behcet's disease	0.000307	0.000888	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—APOB—Behcet's disease	0.000306	0.000884	CbGpPWpGaD
Bortezomib—PSMA1—Gene Expression—SERPINE1—Behcet's disease	0.000298	0.000862	CbGpPWpGaD
Bortezomib—PSMD1—Gene Expression—SERPINE1—Behcet's disease	0.000297	0.000858	CbGpPWpGaD
Bortezomib—PSMD2—Gene Expression—SERPINE1—Behcet's disease	0.000295	0.000854	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—APOA1—Behcet's disease	0.000292	0.000845	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—APOA1—Behcet's disease	0.000291	0.000841	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—APOA1—Behcet's disease	0.000289	0.000837	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—CAT—Behcet's disease	0.000288	0.000833	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—CAT—Behcet's disease	0.000288	0.000833	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—CAT—Behcet's disease	0.000288	0.000833	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—CAT—Behcet's disease	0.000284	0.000822	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—APOB—Behcet's disease	0.00028	0.000809	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—APOB—Behcet's disease	0.00028	0.000809	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—APOB—Behcet's disease	0.00028	0.000809	CbGpPWpGaD
Bortezomib—PSMA1—Disease—SERPINE1—Behcet's disease	0.000277	0.000801	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—APOB—Behcet's disease	0.000276	0.000798	CbGpPWpGaD
Bortezomib—PSMD1—Disease—SERPINE1—Behcet's disease	0.000275	0.000797	CbGpPWpGaD
Bortezomib—PSMD2—Disease—SERPINE1—Behcet's disease	0.000274	0.000793	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—ICAM1—Behcet's disease	0.000272	0.000787	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—ICAM1—Behcet's disease	0.000272	0.000787	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—ICAM1—Behcet's disease	0.000272	0.000787	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—ICAM1—Behcet's disease	0.000268	0.000776	CbGpPWpGaD
Bortezomib—PSMA1—Disease—NOS3—Behcet's disease	0.000264	0.000764	CbGpPWpGaD
Bortezomib—PSMB5—Disease—APOA1—Behcet's disease	0.000264	0.000764	CbGpPWpGaD
Bortezomib—PSMB1—Disease—APOA1—Behcet's disease	0.000264	0.000764	CbGpPWpGaD
Bortezomib—PSMB2—Disease—APOA1—Behcet's disease	0.000264	0.000764	CbGpPWpGaD
Bortezomib—PSMD1—Disease—NOS3—Behcet's disease	0.000263	0.000761	CbGpPWpGaD
Bortezomib—PSMD2—Disease—NOS3—Behcet's disease	0.000262	0.000757	CbGpPWpGaD
Bortezomib—PSMB8—Disease—APOA1—Behcet's disease	0.000261	0.000754	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.00026	0.000751	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—APOA1—Behcet's disease	0.000244	0.000706	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—APOA1—Behcet's disease	0.000243	0.000703	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—APOA1—Behcet's disease	0.000242	0.0007	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—APOB—Behcet's disease	0.000234	0.000676	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—APOB—Behcet's disease	0.000234	0.000676	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—APOB—Behcet's disease	0.000234	0.000676	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000231	0.000669	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—APOB—Behcet's disease	0.000231	0.000667	CbGpPWpGaD
Bortezomib—PSMB5—Gene Expression—SERPINE1—Behcet's disease	0.000226	0.000653	CbGpPWpGaD
Bortezomib—PSMB1—Gene Expression—SERPINE1—Behcet's disease	0.000226	0.000653	CbGpPWpGaD
Bortezomib—PSMB2—Gene Expression—SERPINE1—Behcet's disease	0.000226	0.000653	CbGpPWpGaD
Bortezomib—PSMB8—Gene Expression—SERPINE1—Behcet's disease	0.000223	0.000644	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—APOA1—Behcet's disease	0.000221	0.00064	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—APOA1—Behcet's disease	0.000221	0.00064	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—APOA1—Behcet's disease	0.000221	0.00064	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—NOS3—Behcet's disease	0.000221	0.00064	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—NOS3—Behcet's disease	0.00022	0.000637	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—NOS3—Behcet's disease	0.000219	0.000634	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—APOA1—Behcet's disease	0.000218	0.000631	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000212	0.000613	CbGpPWpGaD
Bortezomib—PSMB2—Disease—SERPINE1—Behcet's disease	0.00021	0.000607	CbGpPWpGaD
Bortezomib—PSMB1—Disease—SERPINE1—Behcet's disease	0.00021	0.000607	CbGpPWpGaD
Bortezomib—PSMB5—Disease—SERPINE1—Behcet's disease	0.00021	0.000607	CbGpPWpGaD
Bortezomib—PSMB8—Disease—SERPINE1—Behcet's disease	0.000207	0.000598	CbGpPWpGaD
Bortezomib—PSMB1—Disease—NOS3—Behcet's disease	0.0002	0.000579	CbGpPWpGaD
Bortezomib—PSMB5—Disease—NOS3—Behcet's disease	0.0002	0.000579	CbGpPWpGaD
Bortezomib—PSMB2—Disease—NOS3—Behcet's disease	0.0002	0.000579	CbGpPWpGaD
Bortezomib—PSMB8—Disease—NOS3—Behcet's disease	0.000197	0.000571	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—SERPINE1—Behcet's disease	0.000194	0.000561	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—SERPINE1—Behcet's disease	0.000193	0.000558	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—SERPINE1—Behcet's disease	0.000192	0.000555	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000189	0.000548	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—NOS3—Behcet's disease	0.000185	0.000535	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—APOA1—Behcet's disease	0.000185	0.000535	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—APOA1—Behcet's disease	0.000185	0.000535	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—APOA1—Behcet's disease	0.000185	0.000535	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—NOS3—Behcet's disease	0.000184	0.000533	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—NOS3—Behcet's disease	0.000183	0.00053	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000183	0.000529	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—APOA1—Behcet's disease	0.000182	0.000528	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000173	0.000499	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000168	0.000485	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—NOS3—Behcet's disease	0.000168	0.000485	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—NOS3—Behcet's disease	0.000168	0.000485	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—NOS3—Behcet's disease	0.000168	0.000485	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—NOS3—Behcet's disease	0.000165	0.000478	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CXCL8—Behcet's disease	0.000164	0.000475	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CXCL8—Behcet's disease	0.000163	0.000473	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—CXCL8—Behcet's disease	0.000163	0.00047	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CAT—Behcet's disease	0.000151	0.000436	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.00015	0.000433	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—APOB—Behcet's disease	0.000148	0.000427	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—SERPINE1—Behcet's disease	0.000147	0.000425	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—SERPINE1—Behcet's disease	0.000147	0.000425	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—SERPINE1—Behcet's disease	0.000147	0.000425	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—APOB—Behcet's disease	0.000146	0.000423	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—SERPINE1—Behcet's disease	0.000145	0.000419	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—NOS3—Behcet's disease	0.00014	0.000406	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—NOS3—Behcet's disease	0.00014	0.000406	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—NOS3—Behcet's disease	0.00014	0.000406	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—NOS3—Behcet's disease	0.000138	0.0004	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000137	0.000395	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CXCL8—Behcet's disease	0.000124	0.00036	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CXCL8—Behcet's disease	0.000124	0.00036	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CXCL8—Behcet's disease	0.000124	0.00036	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CXCL8—Behcet's disease	0.000123	0.000355	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—Behcet's disease	0.000117	0.000338	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—APOA1—Behcet's disease	0.000116	0.000335	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CAT—Behcet's disease	0.000106	0.000307	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—APOB—Behcet's disease	0.000103	0.000298	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CAT—Behcet's disease	9.73e-05	0.000281	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—APOB—Behcet's disease	9.45e-05	0.000273	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—NOS3—Behcet's disease	8.77e-05	0.000254	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CAT—Behcet's disease	8.68e-05	0.000251	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—APOB—Behcet's disease	8.43e-05	0.000244	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—APOA1—Behcet's disease	8.15e-05	0.000236	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CAT—Behcet's disease	7.99e-05	0.000231	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CAT—Behcet's disease	7.92e-05	0.000229	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—APOB—Behcet's disease	7.75e-05	0.000224	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—APOB—Behcet's disease	7.69e-05	0.000222	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—APOA1—Behcet's disease	7.47e-05	0.000216	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CAT—Behcet's disease	6.77e-05	0.000196	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—APOA1—Behcet's disease	6.67e-05	0.000193	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—APOB—Behcet's disease	6.57e-05	0.00019	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—NOS3—Behcet's disease	6.18e-05	0.000179	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—APOA1—Behcet's disease	6.14e-05	0.000177	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—APOA1—Behcet's disease	6.08e-05	0.000176	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—NOS3—Behcet's disease	5.66e-05	0.000164	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CAT—Behcet's disease	5.22e-05	0.000151	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—APOA1—Behcet's disease	5.2e-05	0.00015	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—APOB—Behcet's disease	5.07e-05	0.000147	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—NOS3—Behcet's disease	5.06e-05	0.000146	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—NOS3—Behcet's disease	4.65e-05	0.000134	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—NOS3—Behcet's disease	4.61e-05	0.000133	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—APOA1—Behcet's disease	4.01e-05	0.000116	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NOS3—Behcet's disease	3.94e-05	0.000114	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NOS3—Behcet's disease	3.04e-05	8.79e-05	CbGpPWpGaD
